Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fussenegger

Showing results (101-110 of 330) with videos related to

Pageof 33
Sort By:
Current Opinion in Biotechnology|May 3, 2016
Synthetic biology-application-oriented cell engineeringMingqi Xie, Viktor Haellman, Martin Fussenegger
Metabolic Engineering|November 24, 2018
Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteinsDaniel Bojar, Tobias Fuhrer, Martin Fussenegger
Metabolic Engineering|August 17, 2005
Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particlesBarbara Mitta, Markus Rimann, Martin Fussenegger
Metabolic Engineering|November 27, 2012
Increasing the dynamic control space of mammalian transcription devices by combinatorial assembly of homologous regulatory elements from different bacterial speciesWilliam Bacchus, Wilfried Weber, Martin Fussenegger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2019
Light-Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic BiologyMaysam Mansouri, Tobias Strittmatter, Martin Fussenegger
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2019
A CRISPR/Cas9-based central processing unit to program complex logic computation in human cellsHyojin Kim, Daniel Bojar, Martin Fussenegger
The Journal of Gene Medicine|September 24, 2004
Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage controlCornelia Fux, Dominik Langer, Martin Fussenegger
Methods in Enzymology|May 24, 2011
De novo design and construction of an inducible gene expression system in mammalian cellsMaria Karlsson, Wilfried Weber, Martin Fussenegger
Current Opinion in Chemical Biology|January 28, 2014
Synthetic mammalian gene circuits for biomedical applicationsHaifeng Ye, Dominique Aubel, Martin Fussenegger
Biotechnology and Bioengineering|March 16, 2011
Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cellsImke A J Dreesen, Martin Fussenegger
Pageof 33

Showing results (101-110 of 330) with videos related to

Sort By:
Pageof 33
Current Opinion in Biotechnology|May 3, 2016
Synthetic biology-application-oriented cell engineeringMingqi Xie, Viktor Haellman, Martin Fussenegger
Metabolic Engineering|November 24, 2018
Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteinsDaniel Bojar, Tobias Fuhrer, Martin Fussenegger
Metabolic Engineering|August 17, 2005
Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particlesBarbara Mitta, Markus Rimann, Martin Fussenegger
Metabolic Engineering|November 27, 2012
Increasing the dynamic control space of mammalian transcription devices by combinatorial assembly of homologous regulatory elements from different bacterial speciesWilliam Bacchus, Wilfried Weber, Martin Fussenegger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2019
Light-Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic BiologyMaysam Mansouri, Tobias Strittmatter, Martin Fussenegger
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2019
A CRISPR/Cas9-based central processing unit to program complex logic computation in human cellsHyojin Kim, Daniel Bojar, Martin Fussenegger
The Journal of Gene Medicine|September 24, 2004
Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage controlCornelia Fux, Dominik Langer, Martin Fussenegger
Methods in Enzymology|May 24, 2011
De novo design and construction of an inducible gene expression system in mammalian cellsMaria Karlsson, Wilfried Weber, Martin Fussenegger
Current Opinion in Chemical Biology|January 28, 2014
Synthetic mammalian gene circuits for biomedical applicationsHaifeng Ye, Dominique Aubel, Martin Fussenegger
Biotechnology and Bioengineering|March 16, 2011
Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cellsImke A J Dreesen, Martin Fussenegger
Pageof 33